Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[How to prevent drug therapy risk].

G Bouvenot1

  • 1Laboratoire de thérapeutique, faculté de médecine de Marseille, 13385 Marseille, France. gbouvenot@ap-hm.fr

La Revue De Medecine Interne
|January 25, 2002
PubMed
Summary

Minimizing therapeutic risk involves careful medication use, respecting product information, and considering individual patient needs. Enhanced patient education and advanced risk-prevention tools are crucial for improving drug safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Perception of medication risk by the public and role of the media].

Bulletin de l'Academie nationale de medecine·2022
Same author

[Interfering RNA and antisense oligonucleotide treatments currently available in France: An update].

Bulletin de l'Academie nationale de medecine·2022
Same author

[Potentially inappropriate prescriptions for the elderly: a study of health insurance reimbursements in Southeastern France].

Revue d'epidemiologie et de sante publique·2012
Same author

Feedback and lessons from the prescription of rimonabant, a drug to be used under strict guidelines, in southeastern France, March 2007 through June 2008.

Revue d'epidemiologie et de sante publique·2011
Same author

Adherence to treatment of osteoporosis: a need for study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007
Same author

Antiplatelet therapy for primary prevention in diabetes.

Diabetes & metabolism·2007

Area of Science:

  • Pharmacology and Therapeutics
  • Patient Safety
  • Drug Risk Management

Context:

  • Therapeutic risk is often foreseeable and preventable through appropriate medication use.
  • Current knowledge on drug benefits versus risks can be incomplete or unclear.
  • Individual patient factors beyond clinical trial data are essential for safe prescribing.

Purpose:

  • To highlight the importance of balancing beneficial drug effects with minimizing adverse events.
  • To emphasize the need for accurate and updated information on medication risks and benefits.
  • To advocate for individualized patient care in prescription practices.

Summary:

  • Effective medication use requires adherence to regulatory guidelines and up-to-date information.
  • Prescribing decisions must consider the specific patient's current condition, not just standard trial data.
  • Prioritizing essential medications and implementing rigorous patient monitoring are key to safety.

Impact:

  • Improved patient protection through public health education and enhanced healthcare professional training.
  • Future advancements include computerized risk prevention systems and comprehensive safety reviews.
  • Addressing therapeutic risk is a significant scientific, economic, and ethical challenge for society.

Related Experiment Videos